Bissulfonamide compounds as agonists of GalR1, compositions, and methods of use

Details for Australian Patent Application No. 2005299771 (hide)

Owner TransTech Pharma, Inc.

Inventors Gopalaswamy, Ramesh; Bondlela, Muralidhar; Simila, Suvi; Gaddam, Bapu; Andrews, Robert C.; Rao, Mohan; Ren, Tan; Mjalli, Adnan M.M.; Davis, Stephen

Agent Pizzeys

Pub. Number AU-A-2005299771

PCT Pub. Number WO2006/047302

Priority 60/620,699 21.10.04 US; 60/670,752 13.04.05 US

Filing date 20 October 2005

Wipo publication date 4 May 2006

International Classifications

C07D 333/62 (2006.01) Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom

A61K 31/18 (2006.01) - Sulfonamides

A61K 31/343 (2006.01) - condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone

A61K 31/381 (2006.01) - having five-membered rings

A61K 31/4436 (2006.01)

C07C 311/29 (2006.01) Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups

C07D 213/42 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 233/54 (2006.01) Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings

C07D 307/82 (2006.01) Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom

C07D 333/34 (2006.01) Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom

C07D 409/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 413/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 413/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 495/04 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms

Event Publications

19 April 2007 PCT application entered the National Phase

  PCT publication WO2006/047302 Priority application(s): WO2006/047302

13 November 2008 Assignment before Grant

  TransTech Pharma, Inc. The application has been assigned to High Point Pharmaceuticals, LLC

19 May 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005299794-Vertically aligning slackless drawbar

2005299767-Eph receptor tumor biomarkers